Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NUVL compared with GMAB: revenue, margins and what each company keeps, and the suppliers and customers both name
NUVL
Nuvalent, Inc.
Change
Mkt cap
Revenue
Revenue
GMAB
Genmab A/S
Change
Mkt cap
Revenue
Revenue
vs
Compare
NUVL
Nuvalent, Inc.
vs
GMAB
Genmab A/S
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NUVL
0
None
Shared
0
No disclosed counterparties: NUVL.
Only GMAB
1
COAG
Hemab Therapeutics
customer
Role chip = supplier or customer
Source: SEC EDGAR
NUVL
Nuvalent, Inc.
Change
123.96
▲
+0.02%
· post 123.96
· delayed
Mkt cap
$9.8B
GMAB
Genmab A/S
Change
54.93
▼
−1.07%
· post 55.06
· delayed
After hours
Nov 4 '26
delayed
Mkt cap
$35.7B
vs
Compare
After hours
Nov 4 '26
delayed
NUVL
Nuvalent, Inc.
vs
GMAB
Genmab A/S
123.96
▲
+0.02%
post 123.96
delayed
Price
54.93
▼
−1.07%
post 55.06
delayed
$9.8B
Mkt cap
$35.7B
Change
Change
NUVL
123.96
▲
+0.02%
vs
GMAB
54.93
▼
−1.07%
After hours
Nov 4 '26
delayed